XE

Xencor Inc

  • CIK: 0001326732
  • EIN: 20-1622502
  • Business address: 111 WEST LEMON AVE, MONROVIA, California, 91016

Information

  • Mailing address
    111 WEST LEMON AVE, MONROVIA, Delaware, 91016
  • Phone
    626-305-5900
  • State location
    California
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
  • Filings
    N/A

About Xencor Inc

Xencor Inc (CIK: 0001326732) is an American company incorporated in the state of California. Head office is located at 111 WEST LEMON AVE, MONROVIA, California, 91016. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Xencor Inc is a public company and trade via Over-The-Counter (OTC).

Ownership

Owner Filings Transaction Date Type of Owner
Klencke Barbara 0001647647 Sep-15-2023 director
Dahiyat Bassil I 0001591312 Mar-02-2023 director, officer: PRESIDENT & CEO
Desjarlais John R 0001591313 Mar-02-2023 officer: SR. VICE PRESIDENT & CSO
Eckert Celia 0001787397 Mar-02-2023 officer: VP, GENERAL COUNSEL
Kuch John J 0001591306 Dec-31-2022 officer: SR. VICE PRESIDENT & CFO
Yang Allen 0001797034 Dec-19-2022 officer: SR. VICE PRESIDENT & CMO
Valente Nancy 0001891344 Sep-08-2022 director
GORMAN KEVIN CHARLES 0001201096 Jun-23-2022 director
RANIERI RICHARD J 0001225617 Jun-23-2022 director
Montgomery Alan Bruce 0001313936 Jun-23-2022 director
GUSTAFSON KURT A 0001462354 Jun-23-2022 director
ROSA-BJORKESON DAGMAR 0001643934 Jun-23-2022 director
Hata Yujiro S 0001649119 Jun-23-2022 director
Feigal Ellen 0001758108 Jun-23-2022 director
STAFFORD JOHN S III 0001218981 Aug-09-2016 10 percent owner
Ronin Capital, LLC 0001512282 Aug-09-2016 10 percent owner
ROWLAND LLOYD A 0001236395 Aug-29-2014 officer: Sr. V.P. and General Counsel
Ronin Trading, LLC 0001611042 Jun-12-2014 10 percent owner
WERNER HAROLD R 0001013603 Dec-02-2013 director
STAFFORD JOHN S JR 0001034005 Dec-02-2013 10 percent owner
CARTER BRUCE L A 0001225503 Dec-02-2013 director
FLEMING JONATHAN 0001262294 Dec-02-2013 director
Baracchini Edgardo Jr 0001291972 Dec-02-2013 officer: Chief Business Officer
Baltera Robert Jr. 0001536555 Dec-02-2013 director
SARAN ATUL 0001591070 Dec-02-2013 director
Foster Paul A 0001591213 Dec-02-2013 officer: Chief Medical Officer

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Xencor Inc

Filings Format Description Filed/Effective File/Film Number
8-K Document

Current report filing

Acc-no: 0001326732-24-000048 (34 Act) Size: KB		 Sep-12-2024

001-36182

241294920
8-K Document

Current report filing

Acc-no: 0001213900-24-077934 (34 Act) Size: KB		 Sep-12-2024

001-36182

241293988
424B5 Document

Prospectus filed pursuant to Rule 424(b)(5)

Acc-no: 0001213900-24-077933 (33 Act) Size: KB		 Sep-12-2024

333-270030

241293982
424B5 Document

Prospectus filed pursuant to Rule 424(b)(5)

Acc-no: 0001213900-24-077393 (33 Act) Size: KB		 Sep-10-2024

333-270030

241290465
8-K Document

Current report filing

Acc-no: 0001326732-24-000046 (34 Act) Size: KB		 Sep-09-2024

001-36182

241286021
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001326732-24-000043 (34 Act) Size: KB		 Aug-05-2024

001-36182

241174886
8-K Document

Current report filing

Acc-no: 0001326732-24-000041 (34 Act) Size: KB		 Aug-05-2024

001-36182

241174747
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001127602-24-020307 ( Act) Size: 0 KB		 Jul-11-2024

144 Document

Filing for proposed sale of securities under Rule 144

Acc-no: 0001959173-24-004825 (33 Act) Size: 0 KB		 Jul-09-2024

001-36182

241107657
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001127602-24-018839 ( Act) Size: 0 KB		 Jun-17-2024

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001127602-24-018836 ( Act) Size: 0 KB		 Jun-17-2024

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001127602-24-018834 ( Act) Size: 0 KB		 Jun-17-2024

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001127602-24-018831 ( Act) Size: 0 KB		 Jun-17-2024

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001127602-24-018829 ( Act) Size: 0 KB		 Jun-17-2024

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001127602-24-018825 ( Act) Size: 0 KB		 Jun-17-2024

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001127602-24-018822 ( Act) Size: 0 KB		 Jun-17-2024

8-K Document

Current report filing

Acc-no: 0001326732-24-000036 (34 Act) Size: KB		 Jun-14-2024

001-36182

241044636
8-K Document

Current report filing

Acc-no: 0001326732-24-000034 (34 Act) Size: KB		 Jun-13-2024

001-36182

241040048
8-K Document

Current report filing

Acc-no: 0001326732-24-000030 (34 Act) Size: KB		 May-09-2024

001-36182

24930697
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001326732-24-000029 (34 Act) Size: KB		 May-09-2024

001-36182

24930315

Recent 20 filings. View all Xencor Inc filings

Reviews

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Frequently Asked Questions

Tags:

  • Xencor Inc overview
  • Xencor Inc job
  • Xencor Inc stock
  • Xencor Inc ownership
  • Xencor Inc CEO
  • Xencor Inc documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Metsera, Inc.
Update: Nov 21, 2024
Curanex Pharmaceuticals Inc
Update: Oct 17, 2024
Apimeds Pharmaceuticals US, Inc.
Update: Sep 26, 2024
Upstream Bio, Inc.
Update: Sep 19, 2024
Bicara Therapeutics Inc.
Update: Aug 23, 2024
Stramsen Biotech, Inc.
Update: May 21, 2024

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 4755 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 2255 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 3185 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 3775 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 2859 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 4618 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 4047 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 3269 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 3864 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by